Tim Schlidt is the Co-Founder and Partner at Palo Santo, the leading U.S.-based psychedelic investment fund.
Topics Discussed:
- The mental health crisis and psychedelics
- Intersection of psychedelics and technology
- Pure plant-derived medicine vs. chemically-synthesized compounds
- Psychedelics investment landscape
Listen to the full episode
Watch on YouTube
This Episode is Sponsored By Regrow
This Episode is Sponsored By Endocanna Health
